Bajaj Healthcare Limited - Asset Resilience Ratio
Bajaj Healthcare Limited (BAJAJHCARE) has an Asset Resilience Ratio of 0.22% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Bajaj Healthcare Limited total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2025)
This chart shows how Bajaj Healthcare Limited's Asset Resilience Ratio has changed over time. See Bajaj Healthcare Limited net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Bajaj Healthcare Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BAJAJHCARE market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs18.47 Million | 0.22% |
| Total Liquid Assets | Rs18.47 Million | 0.22% |
Asset Resilience Insights
- Limited Liquidity: Bajaj Healthcare Limited maintains only 0.22% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Bajaj Healthcare Limited Industry Peers by Asset Resilience Ratio
Compare Bajaj Healthcare Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
Drug Manufacturers - Specialty & Generic | 24.59% |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089 |
Drug Manufacturers - Specialty & Generic | 10.89% |
|
KPC Pharmaceuticals Inc
SHG:600422 |
Drug Manufacturers - Specialty & Generic | 16.37% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Cheng Du Sheng Nuo Biotec Co. Ltd. A
SHG:688117 |
Drug Manufacturers - Specialty & Generic | 3.51% |
|
Jiangsu Jibeier Pharmaceutical Co Ltd
SHG:688566 |
Drug Manufacturers - Specialty & Generic | 5.72% |
Annual Asset Resilience Ratio for Bajaj Healthcare Limited (2015–2025)
The table below shows the annual Asset Resilience Ratio data for Bajaj Healthcare Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 0.22% | Rs18.47 Million ≈ $199.75K |
Rs8.33 Billion ≈ $90.09 Million |
+0.12pp |
| 2024-03-31 | 0.10% | Rs7.54 Million ≈ $81.55K |
Rs7.65 Billion ≈ $82.75 Million |
-0.07pp |
| 2023-03-31 | 0.17% | Rs15.09 Million ≈ $163.17K |
Rs9.01 Billion ≈ $97.49 Million |
-1.36pp |
| 2022-03-31 | 1.53% | Rs110.16 Million ≈ $1.19 Million |
Rs7.21 Billion ≈ $77.98 Million |
+1.40pp |
| 2021-03-31 | 0.13% | Rs6.63 Million ≈ $71.73K |
Rs5.26 Billion ≈ $56.85 Million |
+0.13pp |
| 2020-03-31 | 0.00% | Rs-375.00 ≈ $-4.06 |
Rs3.26 Billion ≈ $35.23 Million |
0.00pp |
| 2015-03-31 | 0.00% | Rs375.00 ≈ $4.06 |
Rs1.46 Billion ≈ $15.77 Million |
-- |
About Bajaj Healthcare Limited
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, … Read more